139 related articles for article (PubMed ID: 7924434)
21. Herpesvirus infections in burn patients.
Hayden FG; Himel HN; Heggers JP
Chest; 1994 Jul; 106(1 Suppl):15S-21S; discussion 34S-35S. PubMed ID: 8020328
[No Abstract] [Full Text] [Related]
22. The role of T cell immunity in infection with the herpes group viruses.
Finberg R; Hom R
Year Immunol; 1986; 2():267-78. PubMed ID: 3033947
[No Abstract] [Full Text] [Related]
23. Cytotoxic T lymphocyte responses against measles virus.
UytdeHaag FG; van Binnendijk RS; Kenter MJ; Osterhaus AD
Curr Top Microbiol Immunol; 1994; 189():151-67. PubMed ID: 7924435
[No Abstract] [Full Text] [Related]
24. Strategies involved in developing an effective vaccine for EBV-associated diseases.
Moss DJ; Schmidt C; Elliott S; Suhrbier A; Burrows S; Khanna R
Adv Cancer Res; 1996; 69():213-45. PubMed ID: 8791683
[No Abstract] [Full Text] [Related]
25. Immunogenicity of herpes simplex virus type 1 mutants containing deletions in one or more alpha-genes: ICP4, ICP27, ICP22, and ICP0.
Brehm M; Samaniego LA; Bonneau RH; DeLuca NA; Tevethia SS
Virology; 1999 Apr; 256(2):258-69. PubMed ID: 10191191
[TBL] [Abstract][Full Text] [Related]
26. Enhanced immunogenicity of HPV 16 E7 fusion proteins in DNA vaccination.
Michel N; Osen W; Gissmann L; Schumacher TN; Zentgraf H; Müller M
Virology; 2002 Mar; 294(1):47-59. PubMed ID: 11886264
[TBL] [Abstract][Full Text] [Related]
27. Herpesviruses--immune escape artists?
Banks TA; Rouse BT
Clin Infect Dis; 1992 Apr; 14(4):933-41. PubMed ID: 1315587
[TBL] [Abstract][Full Text] [Related]
28. Active immunization against infection caused by B virus (herpes-virus simiae). 3. Immunoprohylaxis of inhalation infection in rabbits.
Benda R
J Hyg Epidemiol Microbiol Immunol; 1966; 10(1):105-8. PubMed ID: 4288500
[No Abstract] [Full Text] [Related]
29. Herpesvirus infections in the immunocompromised patient.
Skinhøj P
Scand J Infect Dis Suppl; 1985; 47():121-7. PubMed ID: 3006227
[TBL] [Abstract][Full Text] [Related]
30. [Prevention and therapy of herpesvirus infections].
Abb J
Zentralbl Bakteriol Mikrobiol Hyg B; 1985 Feb; 180(2-3):107-20. PubMed ID: 2986378
[TBL] [Abstract][Full Text] [Related]
31. Differences in the recognition of CTL epitopes during primary and secondary responses to herpes simplex virus infection in vivo.
Nugent CT; McNally JM; Chervenak R; Wolcott RM; Jennings SR
Cell Immunol; 1995 Oct; 165(1):55-64. PubMed ID: 7545549
[TBL] [Abstract][Full Text] [Related]
32. Herpesviruses and the microbiome.
Dreyfus DH
J Allergy Clin Immunol; 2013 Dec; 132(6):1278-86. PubMed ID: 23611298
[TBL] [Abstract][Full Text] [Related]
33. Possible Mechanisms of Acquisition of Herpesvirus Virokines.
Gorshkova EA; Shilov ES
Biochemistry (Mosc); 2016 Nov; 81(11):1350-1357. PubMed ID: 27914460
[TBL] [Abstract][Full Text] [Related]
34. [Clinical and immunological correlations in patients with disseminated encephalomyelitis and persistent herpes infection].
Sokolova LI; Kruhliak HO
Lik Sprava; 2005 Jun; (4):51-5. PubMed ID: 16158717
[TBL] [Abstract][Full Text] [Related]
35. Herpesviruses and immunity: the art of evasion.
Griffin BD; Verweij MC; Wiertz EJ
Vet Microbiol; 2010 Jun; 143(1):89-100. PubMed ID: 20303681
[TBL] [Abstract][Full Text] [Related]
36. Questions long-term immunity in cats.
Norsworthy GD
J Am Vet Med Assoc; 1999 Aug; 215(3):316-7. PubMed ID: 10434959
[No Abstract] [Full Text] [Related]
37. [Modulation of immune system by virus infection].
Yasukawa M
Rinsho Byori; 2006 Feb; 54(2):159-69. PubMed ID: 16548237
[TBL] [Abstract][Full Text] [Related]
38. Human cytotoxic T cell clones directed against herpes simplex virus-infected cells. II. Bifunctional clones with cytotoxic and virus-induced proliferative activities exhibit herpes simplex virus type 1 and 2 specific or type common reactivities.
Yasukawa M; Zarling JM
J Immunol; 1984 Nov; 133(5):2736-42. PubMed ID: 6207243
[TBL] [Abstract][Full Text] [Related]
39. Class-specific antibody responses to early and late antigens of varicella and herpes simplex viruses.
Schmidt NJ; Gallo D
J Med Virol; 1984; 13(1):1-12. PubMed ID: 6319583
[TBL] [Abstract][Full Text] [Related]
40. Isolation of cytotoxic T lymphocytes from healthy seropositive individuals specific for peptide epitopes from Epstein-Barr virus nuclear antigen 1: implications for viral persistence and tumor surveillance.
Khanna R; Burrows SR; Steigerwald-Mullen PM; Thomson SA; Kurilla MG; Moss DJ
Virology; 1995 Dec; 214(2):633-7. PubMed ID: 8553567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
